Vivani Medical
Tracked across 2 events · 13 articles · First seen Jun 25, 2026 · Last active Jun 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Vivani Medical received regulatory approval to initiate its SLIM-1 Phase 1 clinical trial for NPM-139, a semaglutide implant, which is a significant step in its product development and could positively impact its market position.
Jun 25, 2026 · 7 articles
Business
Impact: Vivani Medical announced the appointment of August Moretti to its board of directors and the retirement of Dr. Daniel Baker. This change is expected to bring new expertise to the company as it advances its clinical-stage drug implants.
Jun 26, 2026 · 6 articles
100
Vivani Medical received approval BellberryVivani Medical SLIM-1...
100
Vivani Medical appointed August MorettiVivani Medical Board Changes
90
Bellberry approved initiation Vivani MedicalVivani Medical SLIM-1...
80
Vivani Medical announced retirement Daniel BakerVivani Medical Board Changes
ERGEN INTELLIGENCE
Track Vivani Medical live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard